Advanced Search
Conferences

Eurotox 2016

The 52nd Congress of EUROTOX will take place in Seville, Spain, 4th-7th September 2016 and organized by the Turkish Society of Toxicology. EUROTOX is a Federation of 34 European National Societies of Toxicology, with more than 7000 members. The theme of the 52nd congress is “Protecting Public and Environmental Health by Understanding and Communicating Toxicology” and the scientific programme will highlight significant developments and achievements in the field of toxicology.

More than 900 abstracts were received for the EUROTOX 2016 Seville Congress. The Congress will be carried out with 6 Continuing Education Courses, 16 Symposia, 10 Workshops, as well as Keynote Lectures from key scientists. Over 50 companies/CROs provided their supports as exhibitors, enhancing the scientific impact of the congress.

 

Find us @ booth #46

Past
  • September 4-7, 2016

  • Eurotox 2016

  • FIBES, Conference and Exhibition Center, Avda. Alcalde Luis Urunuela 1, Seville 41020, Spain

Schedule

5 September

14:00 to 14:10

J Szostak

Long term exposure to cigarette smoke impacts genes involved in cardiac muscle structure and function in Apoe-/- mouse while exposure to a candidate modified risk tobacco product, the Tobacco Heating System 2.2 (THS2.2) aerosol does not

szostak eurotox 2016 long term exposure to cigarette smoke impacts genes
3766 KB

5 September

14:10 to 14:20

D McHugh

Evaluation of the candidate modified risk tobacco product THS2.2 in a battery of in vitro genotoxicity and cytotoxicity tests

mchugh eurotox 2016 evaluation of the candidate modified risk tobacco product ths2.2
296 KB

5 September

14:20 to 14:30

D Marescotti

High Content Screening (HCS) approach to characterize phenotypic changes occurring during long-term treatment of human bronchial epithelial cells with cigarette smoke total particulate matter

marescotti eurotox 2016 high content screening hcs approach to characterize
12016 KB

5 September

14:30 to 14:40

K Luettich

D Bovard

Establishment and characterization of a lung/liver organ-on-a-chip model. Phase 1: Model characterization

Coming soon

5 September

14:40 to 14:50

JND Battey

Genomic analysis of L5178Y tk+/- cells and their induced tk-/- mutant colonies

battey eurotox 2016 genomic analysis of l5178y tk cells and their induced tk mutant colonies
222 KB

5 September

14:50 to 15:00

M Smith

C Goujon-Ginglinger

Indoor air chemistry - An exploratory study on e-cigarette shows no negative impact on indoor air quality

smith eurotox 2016 indoor air chemistry - an exploratory study on e-cigarette shows no negative impact on indoor
145 KB

5 September

15:00 to 15:10

B Phillips

Toxicity of aerosols of propylene glycol, vegetable glycerin and nicotine in Sprague-Dawley rats in a 90d OECD 413 sub-chronic inhalation study

phillips eurotox 2016 toxicity of aerosols of propylene glycol vegetable glycerin and nicotine
410 KB

5 September

15:10 to 15:20

A Oviedo

Toxicological characterization of the mentholated heat-not-burn product THS2.2M in a 90-day OECD inhalation study

Coming soon

5 September

15:20 to 15:30

D Smart

Performance of the flow cytometry-based in vitro micronucleus assay in a validation study

smart eurotox 2016 performance of the flow cytometry based in vitro micronucleus assay
322 KB

5 September

15:30 to 15:40

F Lüdicke

Reduced exposure to harmful and potentially harmful constituents after 90 days of use of tobacco heating system 2.2 in Japan: a comparison with continued cigarette use or smoking abstinence

luedicke eurotox 2016 reduced exposure to harmful and potentially harmful constituents
767 KB
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.